NASDAQ:MNKD
MannKind Corporation Stock News
$4.39
+0.0100 (+0.228%)
At Close: May 03, 2024
MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30
10:05am, Wednesday, 27'th Apr 2022 GlobeNewswire Inc.
WESTLAKE VILLAGE, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patie
MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference
10:05am, Monday, 28'th Mar 2022 GlobeNewswire Inc.
DANBURY, Conn., March 28, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with e
MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference
06:05am, Monday, 28'th Mar 2022
DANBURY, Conn., March 28, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with end
MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease Summit
10:05am, Tuesday, 22'nd Mar 2022 GlobeNewswire Inc.
DANBURY, Conn., March 22, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with e
These are the stocks to own as inflation starts to slow
03:03pm, Friday, 11'th Mar 2022 MarketWatch
Small-cap and low-momentum strategies tend to do best.
MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare Conference
11:05am, Tuesday, 08'th Mar 2022 GlobeNewswire Inc.
DANBURY, Conn., March 08, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with e
68 Biggest Movers From Yesterday
08:53am, Thursday, 03'rd Mar 2022 Benzinga
Gainers ECMOHO Limited (NASDAQ: MOHO ) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP ) shares jumped 39.2% to close at $2.06 after dipping 37% on Tuesday. Nordstrom, Inc. (NYSE: JWN ) shares jumped 37.8% to settle at $26.93 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 guidance. Regulus Therapeutics Inc. (NASDAQ: RGLS ) gained 35.6% to close at $0.3050. Indonesia Energy Corporation Limited (NASDAQ: INDO ) surged 34.5% to close at $14.50. Trevi Therapeutics, Inc. (NASDAQ: TRVI ) gained 32% to settle at $1.15. Arlo Technologies, Inc. (NYSE: ARLO ) rose 28.9% to close at $11.19 after the company reported better-than-expected Q4 results. The company also issued Q1 sales guidance above analyst estimates. Rocky Brands, Inc. (NASDAQ: RCKY ) climbed 26.6% to close at $47.47 following better-than-expected Q4 results. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC ) gained 26.1% to close at $0.2181.
4 Penny Stocks Insiders Are Buying: MannKind, Crexendo And More
06:19pm, Wednesday, 02'nd Mar 2022 Benzinga
Russian unemployment rate rose to a five-month high of 4.4% in January from 4.3% in the prior month. Investors, meanwhile, focused on some notable insider trades
When insiders purchase or sell shares,
4 Penny Stocks Insiders Are Buying: MannKind, Crexendo And More
06:19pm, Wednesday, 02'nd Mar 2022 Benzinga
Russian unemployment rate rose to a five-month high of 4.4% in January from 4.3% in the prior month. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. Crexendo The Trade: Crexendo, Inc. (NASDAQ: CXDO ) CEO Steven G Mihaylo acquired a total of 3,000 shares at an average price of $4.42. To acquire these shares, it cost $13.25 … Full story available on Benzinga.com
United Therapeutics (UTHR) Q4 Earnings & Sales Miss, Stock Down
03:45pm, Friday, 25'th Feb 2022 Zacks Investment Research
United Therapeutics (UTHR) fourth-quarter earnings and sales miss estimates. Higher sales of Tyvaso and Unituxin mainly drive the top line in the quarter, offset by lower sales of other drugs.
MannKind Corporation (MNKD) Q4 2021 Earnings Call Transcript
05:30am, Friday, 25'th Feb 2022 The Motley Fool
MNKD earnings call for the period ending December 31, 2021.
MannKind Corporation (MNKD) Q4 2021 Earnings Call Transcript
05:30am, Friday, 25'th Feb 2022 The Motley Fool
MNKD earnings call for the period ending December 31, 2021.